HNRNPA1 and cancer: In paired sample (cancer/NM from each same patient) comparison (Table 2) of stomach samples, only HNRNPA1 showed >50 % upregulation (cancer/NM >2) incidence (UI), followed by the other UIs in the order of HNRNPA1 (52 %), SRSF7 (42 %), and other SF proteins (22 %–33 %).